HOME >> MEDICINE >> NEWS
Insulin resistance intervention after stroke focus of $33 million grant

Researchers at Yale School of Medicine and over 60 collaborating research sites received a $33 million grant from the National Institutes of Neurological Disorders and Stroke (NINDS) to conduct a multi-center trial examining a novel approach for treating patients with stroke.

The Insulin Resistance Intervention after Stroke (IRIS) trial will study the effectiveness of a commonly-prescribed medication, pioglitazone, for preventing recurrent stroke and myocardial infarction among non-diabetic patients with a recent ischemic stroke and insulin resistance. The IRIS trial represents a novel approach to stroke prevention, addressing insulin resistance, a common, but often unrecognized risk factor.

Insulin resistance may lead to diabetes, stroke and myocardial infarction. By some estimates, insulin resistance affects up to 50 percent of stroke patients. The drug being tested, pioglitazone, reduces insulin resistance and is currently approved for use in diabetes treatment, but it has not been tested for prevention of vascular disease in non-diabetic patients.

Over 400,000 Americans survive an ischemic stroke each year. Stroke is the third leading cause of death in the United States. Despite current treatment, within four years of the initial event, 16 percent of stroke patients will have a recurrent stroke and 9 percent will have a myocardial infarction. "Prevention of further vascular events, therefore, is of major importance," said principal investigator Walter N. Kernan, M.D., associate professor of medicine at Yale School of Medicine.

The IRIS trial includes over 60 research centers in the United States and Canada that will recruit 3,136 participants in the next three years. Eligible participants are men and women age 45 or over without diabetes who have insulin resistance and a recent ischemic stroke. The participants will be randomly assigned to pioglitazone or placebo in addition to their usual therapy. "We have designed the trial to t
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
20-Jan-2005


Page: 1 2

Related medicine news :

1. Audio conference: Insulin resistance and polycystic ovary syndrome
2. Insulin pumps effective for children with diabetes
3. Insulin pump benefits preschoolers with diabetes
4. Insulin decreases inflammation, aids clot-busting drugs in heart attack patients, UB study shows
5. Insulin-producing cells found in a variety of tissues in diabetes
6. Insulin sensitizer has anti-inflammatory effect in diabetics
7. Insulin pump effective for infants, children
8. Insulin precursor linked with increased stroke risk; may represent new risk factor
9. Compound That Mimics Insulin Might Lead To Pill For Diabetes, As Reported In The 7 May Issue Of Science
10. Insulin Resistance And Obesity Avoided In Genetically Modified Mice, As Reported In Science
11. Encapsulating Insulin-Producing Cells For Possible Diabetes Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... 06, 2019 , ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, ... WVU Medicine in May 2018, previously served as AHN’s Vice Chair of Pathology and ... October and is also part of the pathology faculty at Drexel University College of ...
(Date:12/6/2019)... ... 2019 , ... Brain Sentinel, Inc. announces it is hosting ... Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term Monitoring”, ... during ictal events;, 2. Review specific sEMG patterns of motor seizures and the ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... resolution ultrasound (HRUS) technology to help their patients more easily detect ruptured silicone ... participating in this study and reporting on his experience. While the FDA currently ...
(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, a trusted resource for ... Degree Programs for 2020. The comprehensive research guide is based on an assessment ... based on curriculum quality, graduation rate, reputation, and post-graduate employment. , The ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 article on NBC ... public transit options. The article highlighted the life-changing or life-ending consequences of some E-scooter ... to a rider fatality after an incident with a vehicle. Los Angeles-based personal injury ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... PORTLAND, Ore. (PRWEB) , ... December 06, 2019 ... ... company focused on development of treatments for psychiatric and neurodegenerative disorders, announced today ... Drug (IND) application for NBTX-001 Inhaler, allowing the Company to initiate its Phase ...
(Date:12/6/2019)... ... December 06, 2019 , ... Plant ... Fruit Garden Supply LLC (a division of Horticultural Holdings LLC) to recommend Plant ... growers. , FFGS is a team of disciplined and energetic plant lovers ...
(Date:12/5/2019)... ... 2019 , ... nView, a leading behavioral health solutions company, ... Chief Product Officer. As the company expands its portfolio of software solutions, Rosenbaum ... market into nView’s product and company growth strategy. Rosenbaum will report directly to ...
Breaking Medicine Technology:
Cached News: